Koofhethile C, Gao C, Chang C, Lian X, Shapiro R, Yu X
AIDS. 2023; 38(3):309-316.
PMID: 37916471
PMC: 10842655.
DOI: 10.1097/QAD.0000000000003776.
Ngoufack Jagni Semengue E, Santoro M, Ndze V, Kae A, Yagai B, Nka A
PLOS Glob Public Health. 2023; 2(10):e0000826.
PMID: 36962573
PMC: 10021461.
DOI: 10.1371/journal.pgph.0000826.
Diallo I, Ouedraogo S, Sawadogo A, Ouedraogo G, Diendere E, Zoungrana J
J Int Assoc Provid AIDS Care. 2022; 21:23259582221143675.
PMID: 36474417
PMC: 9732798.
DOI: 10.1177/23259582221143675.
Zuliani-Alvarez L, Govasli M, Rasaiyaah J, Monit C, Perry S, Sumner R
Nat Microbiol. 2022; 7(11):1762-1776.
PMID: 36289397
PMC: 9613477.
DOI: 10.1038/s41564-022-01247-0.
Tchounga B, Charpentier C, Coffie P, Dabis F, Descamps D, Eholie S
PLoS One. 2020; 15(8):e0236642.
PMID: 32756581
PMC: 7406077.
DOI: 10.1371/journal.pone.0236642.
[HIV-2 infection in Senegal: virological failures and resistance to antiretroviral drugs (ARVs)].
Ba S, Dia-Badiane N, Hawes S, Fortes Deguenonvo L, Sall F, Ndour C
Pan Afr Med J. 2019; 33:222.
PMID: 31692792
PMC: 6814923.
DOI: 10.11604/pamj.2019.33.222.15771.
Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana.
Abana C, Sagoe K, Bonney E, Maina E, Aziati I, Agbosu E
Medicine (Baltimore). 2019; 98(6):e14313.
PMID: 30732150
PMC: 6380870.
DOI: 10.1097/MD.0000000000014313.
Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali.
Togo J, Maiga A, Sylla M, Kone B, Dolo O, Traore F
AIDS Res Hum Retroviruses. 2018; 35(2):145-149.
PMID: 30560678
PMC: 6422007.
DOI: 10.1089/AID.2017.0296.
p24 revisited: a landscape review of antigen detection for early HIV diagnosis.
Gray E, Bain R, Varsaneux O, Peeling R, Stevens M, McKendry R
AIDS. 2018; 32(15):2089-2102.
PMID: 30102659
PMC: 6139023.
DOI: 10.1097/QAD.0000000000001982.
A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal,....
Ba S, Raugi D, Smith R, Sall F, Faye K, Hawes S
Clin Infect Dis. 2018; 67(10):1588-1594.
PMID: 29672676
PMC: 6927863.
DOI: 10.1093/cid/ciy324.
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).
Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L
Clin Infect Dis. 2018; 67(8):1161-1167.
PMID: 29590335
PMC: 6160602.
DOI: 10.1093/cid/ciy245.
Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
Alvarez M, Nevot M, Mendieta J, Martinez M, Menendez-Arias L
J Biol Chem. 2017; 293(7):2247-2259.
PMID: 29275329
PMC: 5818179.
DOI: 10.1074/jbc.RA117.000177.
Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test.
Chang M, Steinmetzer K, Raugi D, Smith R, Ba S, Sall F
J Clin Virol. 2017; 97:22-25.
PMID: 29096389
PMC: 5700839.
DOI: 10.1016/j.jcv.2017.10.013.
Humanized Mouse Models for Human Immunodeficiency Virus Infection.
Marsden M, Zack J
Annu Rev Virol. 2017; 4(1):393-412.
PMID: 28746819
PMC: 6542458.
DOI: 10.1146/annurev-virology-101416-041703.
MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture.
Wu V, Smith R, Masoum S, Raugi D, Ba S, Seydi M
Antimicrob Agents Chemother. 2017; 61(8).
PMID: 28559249
PMC: 5527656.
DOI: 10.1128/AAC.00744-17.
Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra.
Rawson J, Gohl D, Landman S, Roth M, Meissner M, Peterson T
J Mol Biol. 2017; 429(15):2290-2307.
PMID: 28502791
PMC: 5557043.
DOI: 10.1016/j.jmb.2017.05.010.
Male Circumcision and the Epidemic Emergence of HIV-2 in West Africa.
Sousa J, Temudo M, Hewlett B, Camacho R, Muller V, Vandamme A
PLoS One. 2016; 11(12):e0166805.
PMID: 27926927
PMC: 5142780.
DOI: 10.1371/journal.pone.0166805.
Effect of sex and age on outcomes among HIV-2-infected patients starting antiretroviral therapy in West Africa.
Tchounga B, Honge B, Eholie S, Coffie P, Jespersen S, Wejse C
AIDS. 2016; 30(17):2707-2714.
PMID: 27536979
PMC: 5841585.
DOI: 10.1097/QAD.0000000000001232.
Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.
Auld A, Blain M, Ekra K, Kouakou J, Ettiegne-Traore V, Tuho M
PLoS One. 2016; 11(6):e0157059.
PMID: 27275742
PMC: 4898722.
DOI: 10.1371/journal.pone.0157059.
Mortality and survival patterns of people living with HIV-2.
Tchounga B, Ekouevi D, Balestre E, Dabis F
Curr Opin HIV AIDS. 2016; 11(5):537-544.
PMID: 27254747
PMC: 5055442.
DOI: 10.1097/COH.0000000000000299.